Silexion Therapeutics Corp

8-K Other events Aug 3, 2026 8-K Director or officer change Jul 31, 2026 8-K Regulation FD disclosure Jul 29, 2026 8-K Amended charter or bylaws; Shareholder vote results Jul 21, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events May 29, 2026 8-K Other events May 26, 2026 10-K/A Fiscal year ended 2025-12-31 May 19, 2026 8-K Results of operations (earnings release) May 18, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Unregistered sale of equity May 15, 2026 8-K Regulation FD disclosure May 14, 2026 8-K Regulation FD disclosure May 13, 2026 8-K Amended charter or bylaws; Shareholder vote results May 5, 2026 8-K Regulation FD disclosure Apr 28, 2026 8-K Director or officer change Mar 25, 2026 8-K Regulation FD disclosure Mar 24, 2026 8-K Shareholder vote results Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Regulation FD disclosure Feb 3, 2026 8-K Regulation FD disclosure Jan 6, 2026 8-K Regulation FD disclosure Dec 16, 2025 8-K Regulation FD disclosure Dec 2, 2025 8-K Regulation FD disclosure Nov 25, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Regulation FD disclosure Sep 30, 2025 8-K Entered a material agreement Sep 26, 2025 8-K Other events Sep 25, 2025 8-K Unregistered sale of equity; Other events Sep 15, 2025 8-K Entered a material agreement Sep 12, 2025 8-K Regulation FD disclosure Sep 11, 2025 8-K Regulation FD disclosure Sep 4, 2025 8-K Regulation FD disclosure Sep 2, 2025 8-K Other events Aug 20, 2025 8-K Amended charter or bylaws; Shareholder vote results Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 1, 2025 8-K Regulation FD disclosure Jul 31, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jul 29, 2025